Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin kinetics during systemic inflammation after major abdominal surgery
2010-018529-21Phase 4Completed
- Sponsor
- Karolinska Institutet
- Start
- Mar 2010
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of iodinated (125I) human albumin in Systemic Inflammatory Response Syndrome (SIRS), sponsored by Karolinska Institutet. Primary endpoints: Fractional synthesis rate of albumin and Absolute synthesis rate of albumin. Started Mar 2010; status: completed.
02
Drugs
iodinated (125I) human albumin
03
Conditions
Systemic Inflammatory Response Syndrome (SIRS)
Beyond the preview
Go deeper on 2010-018529-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018529-21.